To investigate whether pharmacological inhibition of FOXO1 can inhibit PEL cells, we treated cells with AS1842856, a small molecule that specifically binds to and inhibits FOXO1 [44]. This evidence concerns the gene FOXO1 and primary effusion lymphoma.